Ten outstanding research teams will receive $1.8M after being selected recipients of Canada's first cancer funding competition totally designed by cancer patients for cancer patients
When autocomplete results are available use up and down arrows to review and enter to select.
Understanding the molecular underpinnings of high recurrence rates in oral squamous cell carcinoma to improve survival and quality of life for patients
The Princess Margaret Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine...